{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:03:19Z","timestamp":1763017399804,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jaapos.2013.12.009","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T04:45:31Z","timestamp":1396241131000},"page":"120-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Andree","family":"Henaine-Berra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Garcia-Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Quiroz-Mercado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ana","family":"Martinez-Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2013.12.009_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1172\/JCI0214362","article-title":"Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms","volume":"109","author":"Stalmans","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaapos.2013.12.009_bib2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1242\/dev.01732","article-title":"Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes","volume":"132","author":"West","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.jaapos.2013.12.009_bib3","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor\u00a0(VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jaapos.2013.12.009_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity Revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2013.12.009_bib5","first-page":"1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"21","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2013.12.009_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity","volume":"38","author":"Travassos","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"3 Suppl","key":"10.1016\/j.jaapos.2013.12.009_bib7","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","article-title":"Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity","volume":"28","author":"Quiroz-Mercado","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2013.12.009_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2013.12.009_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/IAE.0b013e318275394a","article-title":"Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up","volume":"33","author":"Mart\u00ednez-Castellanos","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2013.12.009_bib10","first-page":"5","article-title":"Astrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature","volume":"29","author":"Scott","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaapos.2013.12.009_bib11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0161-6420(00)00050-6","article-title":"Development of the foveal avascular zone","volume":"107","author":"Gariano","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2013.12.009_bib12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0161-6420(99)00732-0","article-title":"A\u00a0small foveal avascular zone may be an historic mark of prematurity","volume":"106","author":"Mintz-Hittner","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2013.12.009_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ophtha.2010.04.021","article-title":"Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity","volume":"118","author":"Lepore","year":"2011","journal-title":"Ophthalmology"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853114000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853114000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:19:37Z","timestamp":1761077977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853114000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1091853114000779"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2013.12.009","relation":{},"ISSN":["1091-8531"],"issn-type":[{"type":"print","value":"1091-8531"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2013.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}